Add to Calendar 10/1/2021 11:00:00 AM 10/1/2021 4:00:00 PM Patient Advocacy Summit 2021 This event is now virtual. MassBio's Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization, but throughout the drug development cycle.

The program includes opening and closing keynote addresses, a panel discussion, and a professional development workshop for Patient Advocates.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Virtual,
Writer / Editor / Consultant / Rare Disease Adviser
For more than 20 years, I have worked as a writer and provided editorial support and guidance and strategic consultation to medical nonprofits and pharmaceutical and biotechnology companies. I have extensive experience writing about rare disorders for both patients (in lay terminology) and physicians (in medical terminology). At one time, I oversaw the development and expansion of the National Organization for Rare Disorder’s Rare Disease Database. I understand the unique needs of patients in the rare disease community and work to foster better communication and understanding between these diverse groups and the industry representatives that work with them. My projects have included helping to start and guide a nonprofit organization, running a competitive grants program, and creating the content and format for a lecture series on rare disorders and identifying and engaing the physician experts. Professional Patient Advocates in Life Sciences (PPALS) I am part of the founding faculty for PPALS and work to build recognition of this vital role in life sciences and to foster better relationships between PAO leadership and the Patient Advocacy professionals who serve them. WHY RARE DISEASES? There are over 7,000 rare diseases. Many are genetic, many affect children. Most of these disorders do not have an FDA-approved treatment. I realized that my efforts could make a difference - however small - in a community that has been long ignored.

Brought to you by